1
|
Mothe B, Bailon L, Llano A, Alarcon-Soto Y, Brander C. OP 8.3 – 00028 HIV-vaccine induced, broad and polyfunctional CD4 and CD8 T cell responses are associated with prolonged time off ART and lower pVL at the end of ATI in the AELIX-002 therapeutic vaccine trial. J Virus Erad 2022. [DOI: 10.1016/j.jve.2022.100277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
|
2
|
Bouza E, Arribas JR, Alejos B, Bernardino JI, Coiras M, Coll P, Del Romero J, Fuster MJ, Górgolas M, Gutiérrez A, Gracia D, Hernando V, Martínez-Picado J, Martínez Sesmero JM, Martínez E, Moreno S, Mothe B, Navarro ML, Podzamczer D, Pulido F, Ramos JT, Ruiz-Mateos E, Suárez García I, Palomo E. Past and future of HIV infection. A document based on expert opinion. Rev Esp Quimioter 2022; 35:131-156. [PMID: 35018404 PMCID: PMC8972691 DOI: 10.37201/req/083.2021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
HIV infection is now almost 40 years old. In this time, along with the catastrophe and tragedy that it has entailed, it has also represented the capacity of modern society to take on a challenge of this magnitude and to transform an almost uniformly lethal disease into a chronic illness, compatible with a practically normal personal and relationship life. This anniversary seemed an ideal moment to pause and reflect on the future of HIV infection, the challenges that remain to be addressed and the prospects for the immediate future. This reflection has to go beyond merely technical approaches, by specialized professionals, to also address social and ethical aspects. For this reason, the Health Sciences Foundation convened a group of experts in different aspects of this disease to discuss a series of questions that seemed pertinent to all those present. Each question was presented by one of the participants and discussed by the group. The document we offer is the result of this reflection.
Collapse
Affiliation(s)
- E Bouza
- Servicio de Microbiología Clínica y Enfermedades Infecciosas del Hospital General Universitario Gregorio Marañón, Universidad Complutense. CIBERES. Ciber de Enfermedades Respiratorias. Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Gálvez C, Urrea V, Benet S, Mothe B, Bailón L, Dalmau J, Leal L, García F, Martinez-Picado J, Salgado M. Low viral reservoir treated individuals show unusual HIV latency distribution. J Virus Erad 2019. [DOI: 10.1016/s2055-6640(20)30134-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
4
|
Tjok Joe P, Guardo A, Miralles L, Bargalló M, Maleno M, Mothe B, Krasniqi A, Heirman C, García F, Gatell J, Thielemans K, Brander C, Plana M, Aerts J. P4 Preclinical evaluation of an mRNA-based therapeutic HIV vaccine candidate combining rationally selected antigenic sequences and potent adjuvant signals (HTI-TriMix). J Virus Erad 2016. [DOI: 10.1016/s2055-6640(20)31091-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
5
|
Morón-López S, Mothe B, Manzardo C, Sanchez-Bernabeu A, Coll P, Puertas M, Dorrell L, Miró J, Clotet B, Brander C, Martinez-Picado J, Hanke T. HIV conserved region vaccine in early cART-treated subjects (BCN01): impact on immunogenicity and the latent reservoir. J Virus Erad 2015. [DOI: 10.1016/s2055-6640(20)31333-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
6
|
Chereshnev VA, Bocharov G, Bazhan S, Bachmetyev B, Gainova I, Likhoshvai V, Argilaguet JM, Martinez JP, Rump JA, Mothe B, Brander C, Meyerhans A. Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective. Int Rev Immunol 2013; 32:282-306. [PMID: 23617796 DOI: 10.3109/08830185.2013.779375] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Infections with HIV represent a great challenge for the development of strategies for an effective cure. The spectrum of diseases associated with HIV ranges from opportunistic infections and cancers to systemic physiological disorders like encephalopathy and neurocognitive impairment. A major progress in controlling HIV infection has been achieved by highly active antiretroviral therapy (HAART). However, HAART does neither eliminate the virus reservoirs in form of latently infected cells nor does it completely reconstitute immune reactivity and physiological status. Furthermore, the failure of the STEP vaccine trial and the only marginal efficacies of the RV144 trial together suggest that the causal relationships between the complex sets of viral and immunological processes that contribute to protection or disease pathogenesis are still poorly understood. Here, we provide an up-to-date overview of HIV-host interactions at the cellular, the immune system and the neuroendocrine systems level. Only by integrating this multi-level knowledge one will be able to handle the systems complexity and develop new methodologies of analysis and prediction for a functional restoration of the immune system and the health of the infected host.
Collapse
Affiliation(s)
- V A Chereshnev
- Institute of Immunology and Physiology, Ural Branch RAS, Ekaterinburg, Russia.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Llano A, Carrillo J, Mothe B, Marfil S, García E, Ruiz L, Yuste E, Sanchez V, Blanco J, Brander C. Modulation of antibody secreting cells and neutralizing Ab activity in HIV infected individuals undergoing structured treatment interruptions. Retrovirology 2012; 9. [PMCID: PMC3442083 DOI: 10.1186/1742-4690-9-s2-p63] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- A Llano
- IrsiCaixa AIDS Research Institute, Barcelona, Spain
| | - J Carrillo
- IrsiCaixa AIDS Research Institute, Barcelona, Spain
| | - B Mothe
- IrsiCaixa AIDS Research Institute, Barcelona, Spain
| | - S Marfil
- IrsiCaixa AIDS Research Institute, Barcelona, Spain
| | - E García
- IrsiCaixa AIDS Research Institute, Barcelona, Spain
| | - L Ruiz
- IrsiCaixa AIDS Research Institute, Barcelona, Spain
| | - E Yuste
- Institut d'Investigacions Biomediques August Pi i Sunter, Barcelona, Spain
| | - V Sanchez
- Institut d'Investigacions Biomediques August Pi i Sunter, Barcelona, Spain
| | - J Blanco
- IrsiCaixa AIDS Research Institute, Barcelona, Spain
| | - C Brander
- IrsiCaixa AIDS Research Institute, Barcelona, Spain
| |
Collapse
|
8
|
Mothe B, Llano A, Rosati M, Perez-Alvarez S, Kulkarni V, Chowdhury B, Alicea C, Beach RK, Sardesai NY, Pavlakis GN, Felber BK, Brander C. A minimal T-cell immunogen designed to cover HIV-1 specificities associated with control is immunogenic in mice and breaks CTL immunodominance. Retrovirology 2012. [PMCID: PMC3441675 DOI: 10.1186/1742-4690-9-s2-p305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
9
|
Pavlakis GN, Kulkarni V, Valentin A, Rosati M, Sardesai NY, Mothe B, Brander C, LeGall S, Weiner DB, Rolland M, Mullins JI, Felber BK. DNA vaccines expressing conserved elements provide potent and broad immune responses. Retrovirology 2012. [PMCID: PMC3441506 DOI: 10.1186/1742-4690-9-s2-o67] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
10
|
Ibarrondo J, Zúñiga R, Farfán M, Suarez J, Mothe B, Llano A, Szinger JJ, Hildebrand W, Sánchez J, Korber BT, Brander C. P16-24. Crucial contribution of sub-dominant HLA-C allele restricted CTL responses to the control of HIV. Retrovirology 2009. [PMCID: PMC2767752 DOI: 10.1186/1742-4690-6-s3-p253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
11
|
Zuniga R, Mothe B, Llano A, Ibarrondo J, Daniels M, Farfan M, Suarez J, Szinger JJ, Hildebrand W, Lucchetti A, Heckerman D, Goulder P, Walker BD, Sanchez J, Korber BT, Brander C. S011-06 OA. HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles. Retrovirology 2009. [PMCID: PMC2767551 DOI: 10.1186/1742-4690-6-s3-o3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
12
|
Mothe B, Llano A, Ibarrondo J, Miranda C, Rolland M, Frahm N, Khatri A, Heckerman D, Mullins J, Brander C. P12-09. Immune responses in controlled and uncontrolled HIV infection to a designed HIV immunogen sequence focused on conserved regions of the viral genome. Retrovirology 2009. [PMCID: PMC2767665 DOI: 10.1186/1742-4690-6-s3-p175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
13
|
Mothe B, Lopez-Contreras J, Torres OH, Muñoz C, Domingo P, Gurgui M. A Case of Hyper-reactive Malarial Splenomegaly. The Role of Rapid Antigen-detecting and PCR-based Tests. Infection 2007; 36:167-9. [PMID: 17906843 DOI: 10.1007/s15010-007-6025-z] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2006] [Accepted: 03/27/2007] [Indexed: 10/22/2022]
Abstract
Hyper-reactive malarial splenomegaly (HMS) - originally referred to as tropical splenomegaly syndrome - is characterized by a massive splenomegaly, high titres of anti-malarial antibodies and polyclonal IgM hypergammaglobulinemia. It is believed to be a consequence of an aberrant immunological response to prolonged exposure to malarial parasites. Although it is a frequent disease in the tropics, it is infrequent in western countries and is only seen in long-term residents from endemic areas. We describe the case of a 67-year-old Spanish man, a missionary in Cameroon for 30 years, who presented with a clinical history that fulfilled the diagnosis of HMS. We discuss the role and importance of PCR-based techniques in demonstrating lowgrade malarial parasitemia and the usefulness of new rapid antigen-detecting dipstick tests.
Collapse
Affiliation(s)
- B Mothe
- Infectious Diseases Unit, Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Universitat de Barcelona, Barcelona, Spain
| | | | | | | | | | | |
Collapse
|
14
|
Sidney J, Dzuris JL, Newman MJ, Johnson RP, Kaur A, Amitinder K, Walker CM, Appella E, Mothe B, Watkins DI, Sette A. Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins. J Immunol 2000; 165:6387-99. [PMID: 11086077 DOI: 10.4049/jimmunol.165.11.6387] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Single amino acid substitution analogs of the known Mamu A*01 binding peptide gag 181-190 and libraries of naturally occurring sequences of viral or bacterial origin were used to rigorously define the peptide binding motif associated with Mamu A*01 molecules. The presence of S or T in position 2, P in position 3, and hydrophobic or aromatic residues at the C terminus is associated with optimal binding capacity. At each of these positions, additional residues are also tolerated but associated with significant decreases in binding capacity. The presence of at least two preferred and one tolerated residues at the three anchor positions is necessary for good Mamu A*01 binding; optimal ligand size is 8-9 residues. This detailed motif has been used to map potential epitopes from SIVmac239 regulatory proteins and to engineer peptides with increased binding capacity. A total of 13 wild type and 17 analog candidate epitopes were identified. Furthermore, our analysis reveals a significantly lower than expected frequency of epitopes in early regulatory proteins, suggesting a possible evolutionary- and/or immunoselection directed against variants of viral products that contain CTL epitopes.
Collapse
Affiliation(s)
- J Sidney
- Epimmune, San Diego, CA 92121. New England Regional Primate Center, Southborough, MA 01772, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|